日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Microglial Fkbp5 Impairs Post-Stroke Vascular Integrity and Regeneration by Promoting Yap1-Mediated Glycolysis and Oxidative Phosphorylation.

小胶质细胞 Fkbp5 通过促进 Yap1 介导的糖酵解和氧化磷酸化损害中风后血管完整性和再生。

Li Yanan, Qiu Yanmei, Yang Yunlei, Wei Yanhao, Peng Haokun, Zeng Longhai, Li Pengcheng, Bi Rentang, Hu Bo

Nanomaterial-Based Anti-Angiogenic Gene Therapy for Retinal Neovascular Diseases: Mechanistic Insights and Preclinical Advances

基于纳米材料的抗血管生成基因疗法治疗视网膜新生血管疾病:机制见解和临床前进展

Zeng, Longhai; Wei, Yanhao; Qiu, Yanmei; Bi, Rentang; Peng, Haokun; Hu, Bo; Li, Ya'nan

Associations of Cerebral Small Vessel Disease and Chronic Kidney Disease in Patients With Acute Ischemic Stroke

急性缺血性卒中患者合并脑小血管病和慢性肾脏病的相关性

Bi, Rentang; Wei, Yanhao; Li, Pengcheng; Peng, Haokun; Alizadeh, Mohammad; Hu, Bo; Li, Yanan

Role of FK506 binding protein 51 in central nervous system diseases

FK506结合蛋白51在中枢神经系统疾病中的作用

Peng, Haokun; Wei, Yanhao; Qiu, Yanmei; Bi, Rentang; Zeng, Longhai; Hu, Bo; Li, Yanan

Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases

用于靶向脑部治疗神经系统疾病的细胞膜包覆纳米颗粒

Li, Jianzhuang; Wei, Yanhao; Zhang, Chunlin; Bi, Rentang; Qiu, Yanmei; Li, Yanan; Hu, Bo

Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue

FDA 批准药物的筛选表明 Sutent 是棕色脂肪组织中 UCP1 表达的调节剂

Yan Qiu, Yingmin Sun, Danqing Xu, Yuanyuan Yang, Xiaojian Liu, Yuda Wei, Yanhao Chen, Zhuanghui Feng, Shuang Li, Md Reyad-Ul Ferdous, Yongxu Zhao, Hongxi Xu, Yuanzhi Lao, Qiurong Ding

SIRT1 inhibition promotes atherosclerosis through impaired autophagy

SIRT1 抑制通过损害自噬促进动脉粥样硬化

Xiaofeng Yang, Jingyuan Wei, Yanhao He, Ting Jing, Yanxiang Li, Yunfang Xiao, Bo Wang, Weirong Wang, Jiye Zhang, Rong Lin